Concepedia

Derek Ostertag

DO

Statistics

Publications

13

Citations

1.4K

H-Index

12

Active since

1999

Affiliations

University of California, Los Angeles(Current)

University of California San Diego

Cleveland Clinic

University of Miami

Henry Ford Hospital

Derek Ostertag is an author at University of California, Los Angeles specializing in oncology, medicine, and pharmacology.

Publications per year

1999–2020

13

Publications

13

JNK2 and IKKβ Are Required for Activating the Innate Response to Viral Infection

Wen-Ming Chu, Derek Ostertag, Zhi-Wei Li et al. · Immunity · 1999 · 387 citations · Full text

, , +16

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

Timothy F. Cloughesy, Joseph Landolfi, Daniel J. Hogan et al. · Science Translational Medicine · 2016 · 199 citations · Full text

, , +16

Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC

Timothy F. Cloughesy, Joseph Landolfi, Michael A. Vogelbaum et al. · Neuro-Oncology · 2018 · 176 citations · Full text

, , +16

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma

Timothy F. Cloughesy, Kevin Petrecca, Tobias Walbert et al. · JAMA Oncology · 2020 · 140 citations · Full text

, , +14

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

Derek Ostertag, Karin Amundson, F. Lopez Espinoza et al. · Neuro-Oncology · 2011 · 137 citations · Full text

, , +12

1–5 of 13